Thus, it has been recently shown that ERCC1-deficient non-small cell lung cancer (NSCLC) cells accumulate cytosolic chromatin fragments and consecutively induce type I IFNs in response to PARP inhibition (Chabanon et al., 2019). Here, ERCC1 is linked to non-small cell lung carcinoma.